$10.2B
$5.57 Million
0.02% of portfolio
318,215
Q4 2024
Added 787.9%
$155M
$6.95 Million
0.02% of portfolio
757,869
Q4 2024
Added 27.96%
$3.77B
$8.39 Million
0.02% of portfolio
131,041
Q4 2024
New
$93.2B
$7.19 Million
0.02% of portfolio
358,731
Q4 2024
Reduced 43.89%
$3.74B
$6.28 Million
0.02% of portfolio
47,761
Q4 2024
Reduced 53.14%
$659M
$7.75 Million
0.02% of portfolio
140,990
Q4 2024
Added 2.82%
$982M
$6.83 Million
0.02% of portfolio
274,647
Q4 2024
New
$11.7B
$5.92 Million
0.02% of portfolio
158,264
Q4 2024
Reduced 0.42%
$540M
$6.82 Million
0.02% of portfolio
225,472
Q4 2024
Added 2.16%
$2.2B
$5.63 Million
0.02% of portfolio
99,341
Q4 2024
Reduced 23.13%
Kiniksa Pharmaceuticals Int Lt
-
$7.56 Million
0.02% of portfolio
-
Q4 2024
Added 260.22%
-
$7.79 Million
0.02% of portfolio
-
Q4 2024
New
-
$8.11 Million
0.02% of portfolio
-
Q4 2024
New
$261M
$5.54 Million
0.02% of portfolio
652,302
Q4 2024
Reduced 10.69%
$1.09B
$7.02 Million
0.02% of portfolio
433,790
Q4 2024
Added 34.07%
$657M
$6.28 Million
0.02% of portfolio
161,967
Q4 2024
Reduced 4.57%
$29.2B
$5.55 Million
0.02% of portfolio
40,741
Q4 2024
Reduced 45.01%
$145B
$5.36 Million
0.02% of portfolio
21,745
Q4 2024
Added 607.15%
$52.5B
$6.17 Million
0.02% of portfolio
55,901
Q4 2024
Reduced 34.3%
$2.41B
$5.54 Million
0.02% of portfolio
957,187
Q4 2024
New
$37.3B
$6.23 Million
0.02% of portfolio
80,597
Q4 2024
Reduced 49.16%
Natures Sunshine Prods Inc
-
$6.83 Million
0.02% of portfolio
-
Q4 2024
Added 7.68%
$139M
$6.69 Million
0.02% of portfolio
7,201,089
Q4 2024
Added 27.34%
$239M
$5.55 Million
0.02% of portfolio
2,343,858
Q4 2024
Added 167.76%
$382M
$5.79 Million
0.02% of portfolio
236,658
Q4 2024
Added 12.36%
-
$7.52 Million
0.02% of portfolio
-
Q4 2024
New
$1.85B
$5.47 Million
0.02% of portfolio
289,413
Q4 2024
New
$10.9B
$7.44 Million
0.02% of portfolio
183,728
Q4 2024
Added 12.97%
$279M
$6.7 Million
0.02% of portfolio
255,306
Q4 2024
Reduced 0.91%
$281M
$5.49 Million
0.02% of portfolio
271,275
Q2 2023
Reduced 2.67%
$451M
$5.63 Million
0.02% of portfolio
487,869
Q3 2024
Reduced 8.33%
$3.05B
$6.02 Million
0.02% of portfolio
78,875
Q4 2024
Added 1,414.79%
$21B
$6.4 Million
0.02% of portfolio
82,676
Q4 2024
Reduced 70.45%
$143M
$6.01 Million
0.02% of portfolio
1,972,128
Q4 2024
Added 0.16%
$1.62B
$5.97 Million
0.02% of portfolio
148,670
Q4 2024
Added 1,586.37%
$5.01B
$5.2 Million
0.02% of portfolio
192,999
Q4 2024
Reduced 52.04%
Rigel Pharmaceuticals Inc
-
$6.33 Million
0.02% of portfolio
-
Q4 2024
Reduced 10.77%
$304M
$5.93 Million
0.02% of portfolio
2,223,982
Q4 2024
Added 1.11%
$44.4B
$7.96 Million
0.02% of portfolio
52,660
Q4 2024
Reduced 83.91%
$694M
$7.92 Million
0.02% of portfolio
577,835
Q4 2024
Added 157.08%
$492M
$8.6 Million
0.02% of portfolio
1,585,415
Q4 2024
Added 67.44%
$870M
$5.2 Million
0.02% of portfolio
109,652
Q4 2024
Added 176.22%
$611M
$6.28 Million
0.02% of portfolio
294,510
Q4 2024
Added 125.65%
$2.26B
$7.36 Million
0.02% of portfolio
148,175
Q4 2024
Reduced 37.75%
-
$5.41 Million
0.02% of portfolio
-
Q4 2024
Added 199.05%
$17.8B
$6.85 Million
0.02% of portfolio
208,370
Q4 2024
Reduced 17.82%
$115B
$6.04 Million
0.02% of portfolio
56,874
Q4 2024
Added 20.5%
$448M
$8.62 Million
0.02% of portfolio
655,800
Q4 2024
Added 36.71%
$324M
$5.93 Million
0.02% of portfolio
369,631
Q4 2024
Reduced 11.68%
$1.11B
$6.96 Million
0.02% of portfolio
165,747
Q4 2024
Added 5.77%